Neurogene Company
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Technology:
Neurological Disorders
Industry:
Gene Therapy
Headquarters:
New York, New York, United States
Founded Date:
2018
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership